Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP

Cancer Research

Volumn 58, Issue 1, 1998, Pages 76-83

  Marcelli, Marco ^a   Cunningham, Glenn R ^a   Haidacher, S Joe ^a   Padayatty, Sebastian J ^a   Sturgis, Lydia ^b   Kagan, Carolina ^b   Denner, Larry ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS BIOTECHNOLOGY CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MESSENGER RNA; MEVALONIC ACID; MEVINOLIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEASE S1; RESTRICTION ENDONUCLEASE;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEINASE INHIBITION;

ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 7; CASPASES; CYSTEINE ENDOPEPTIDASES; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; LOVASTATIN; MALE; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031963951     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Parker, S., Tong, T., Bolder, S., and Wingo, P. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Santen, R. J. Endocrine treatment of prostate cancer. J. Clin. Endocrinol. Metab., 75: 685-689, 1992.
3. Kozlowski, J., Ellis, W., and Grayhack, J. Advanced prostatic carcinoma: early vs late endocrine therapy. Urol. Clin. N. Am., 18: 15-24, 1991.
4. Isaacs, J., and Coffey, D. Adaptation vs selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation as studied in the Dunning R-3327 H adenocarcinoma. Cancer Res., 41: 5070-5075, 1981.
5. Kyprianou, N., English, H., and Isaacs, J. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50: 3748-3753, 1990.
6. Isaacs, J., Lundmo, P., Berges, R., Martikainen, P., Kyprianou, N., and English, H. Androgen regulation of programmed cell death of normal and malignant prostatic cells. J. Androl., 13: 457-464, 1992.
7. Kyprianou, N. Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer. World J. Urol., 12: 299-303, 1994.
8. Kyprianou, N., and Isaacs, J. Thymine-less death in androgen-independent prostate cancer cells. Biochem. Biophys. Res. Commun., 165: 73-81, 1989.
9. Horoszewicz, J., Leong, S., Chu, T., Wajsman, Z., Friedman, M., Papsidero, L., Kim, U., Chai, L., Kakati, S., Arya, S., and Sandberg, A. The LNCAP cell line: a new model for studies on human prostatic carcinoma. In: C. Murphy (ed.), Models for Prostate Cancer, pp. 115-132. New York: A. R. Liss, 1980.
10. Berchem, G. J., Bosseler, M., Sugars, L. Y, Voeller, H. J., Zeitlin, S., and Gelmann, E. P. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res., 55: 735-738, 1995.
11. Veldscholdte, J., Ris-Stalpers, C. Kuiper, G. G. J. M., Jentser, G., Berrevoets, C., Claassen, E., Rooij, H. C. J. V., Trapman, J., Brinkmann, A. O., and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of LnCAP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 173: 534-540, 1990.
12. Alberts, A., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., Lopez, M. R., Joshus, H., Harris, E., Patchett, A., Monagham, R., Currie, S., Stapley, E., Albers-Schonberg, G., Hensens, O., Hirshfield, J., Hoogsteen, K., Liesch, J., and Springer, J. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA, 77: 3957-3961, 1980.
13. Vaux, D., and Strasser, A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA, 93: 2239-2244, 1996.
14. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Lawrence, F., Tomaselli, K., Wang, L., Yu, Z., Croce, C., Salvesen, G., Eamshaw, W., Litwack, G., and Alnemri, E. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res., 55: 6045-6052, 1995.
15. Wyllie, A. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
16. Gavrielli, Y., Sherman, Y., and Ben-Sasson, S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
17. Schwartzman, R., and Cidlowski, J. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev., 14: 133-151, 1993.
18. Kaufmann, S., Desnoyers, S., Ottaviano, Y., Davidson, N., and Poirier, G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
19. Chinnaiyan, A. M., Orth, K., O'Rourke, K., Duan, H., Poirier, G. G., and Dixit, V. M. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem., 271: 4573-4576, 1996.
20. Nicholson, D., Ali, A., Thornberry, N., Vaillancourt, J., Ding, C., Gallant, M., Gareau, Y., Griffin, P., Labelle, M., Lazebnick, Y., Munday, N., Raju, S., Smulson, M., Yamin, T-T., Yu, V., and Miller, D. Identification and inhibition of the ICE/ CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
21. Thornberry, N., Bull, H., Calaycay, J., Chapman, K., Howard, A., Kostura, M., Miller, D., Molineaux, S., Weidner, J., Aunins, J., Ellison, K., Ayala, J., Casano, F., Chin, J., Ding, G. J-F., Egger, L., Gaffney, E., Limjuco, G., Palyha, O., Raju, S., Rolando, A., Salley, J., Yamin, T., Lee, T., Shively, J., MacCross, M., Mumford, R., Schmidt, J., and Tocci, M. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature (Lond.), 356: 768-774, 1992.
22. Enari, M., Talanian, R., Wong, W., and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380: 723-726, 1996.
23. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. CPP32, a novel human apoptotic protein with homology to C. elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem., 269: 30761-30764, 1994.
24. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. Mch2, a new member of the apoptotic Ced3/Ice cysteine protease gene family. Cancer Res., 55: 2737-2742, 1995.
25. Duan, H., Orth, K., Chinnaiyan, A., Poirier, G., Froelich, C., He, W-W., and Dixit, V. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem., 271: 16720-16724, 1996.
26. Marcelli, M., Haidacher, S. J., Plymate, S. R., and Birnbaum, R. S. Altered growth and insulin-like growth factor binding protein-3 (IGFBP-3) production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor cDNA. Endocrinology, 136: 1040-1048, 1995.
27. Lazebnick, Y., Takahashi, A., Moir, R., Goldman, R., Poirier, G., Kaufmann, S., and Earnshaw, W. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92: 9042-9046, 1995.
28. Tewari, M., Quan, L., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D., Poireer, G., Salvesen, G., and Dixit, V. Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
29. Lazebnick, Y., Kaufmann, S., Desnoyers, S., Poirier, G., and Earnshaw, W. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
30. Gu, Y., Sarnecki, C., Aldape, R., Livingston, D., and Su, M. S-S. Cleavage of poly(ADP-ribose) polymerase by interleukin-1β converting enzyme and its homologs TX and Nedd-2. J. Biol. Chem., 270: 18715-18718, 1995.
31. Perez-Sala, D., and Mollinedo, F. Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem. Biophys. Res. Comm., 199: 1209-1215, 1994.
32. Jones, K., Couldwell, W., Hinton, D., Su, Y., Shikun, H., Anker, L., and Law, R. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys. Res. Commun., 205: 1681-1687, 1994.
33. Borner, M., Myers, C., Sartor, O., Sei, Y., Toko, T., Trepel, J., and Schneider, E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative prostate cancer cell line PC3. Cancer Res., 55: 2122-2128, 1995.
34. Padayatty, S., Marcelli, M., Shao, T., and Cunningham, G. Lovastatin-induced apoptosis in prostate stromal cells. J. Clin. Endocrinol. Metab., 82: 1434-1439, 1997.
35. Lutz, R., Trujillo, M., Denham, K., Wenger, L., and Sinensky, M. Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina. Proc. Natl. Acad. Sci. USA. 89: 3000-3004, 1992.
36. Orth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., and Dixit, V. M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem., 271: 16443-16446, 1996.
37. Keyomarsi, K., Sandoval, L., Band, V., and Pardee, A. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res., 51: 3602-3609, 1991.
38. Hengst, L., Dulic, J., Slingerland, E., Lees, E., and Reed, S. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA, 91: 5291-5295, 1994.
39. Gray-Bablin, J., Rao, S., and Keyomarsi, K. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Cancer Res., 57: 604-609, 1997.
40. Alnemri, E., Livingston, D., Nicholson, D., Salvesen, G., Thornberry, N., Wong, W., and Yuan, J. Human ICE/CED3 protease nomenclature. Cell, 87: 171, 1996.
41. Pai, J-T., Brown, M., and Goldstein, J. Purification and cDNA cloning of a second apoptosis related cysteine protease that cleaves and activates sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA, 93: 5437-5442, 1996.
42. Wang, X., Zelenski, N., Yang, J., Sakai, J., Goldstein, J., and Brown, M. Cleavage of sterol-regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J., 15: 1012-1020, 1996.
43. Miller, D. K., The role of the caspase family of cysleine proteases in apoptosis. Semin. Immunol., 9: 35-49, 1997.
44. Liu, X., Zou, H., Slaughter, C., and Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89: 175-184, 1997.
45. Rudel, T., and Bokoch, G. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science (Washington DC), 276: 1571-1574, 1997.
46. Fernandes-Alnemri, T., Armstrong, R., Krebs, J., Srinivasula, S., Wang, L., Bullrich, F., Fritz, L., Trapani, J., Tomaselli, K., Litwack, G., and Alnemri, E. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA, 93: 7464-7469, 1996.
47. Muzio, M., Salvesen, G., and Dixit, V. FLICE induced apoptosis in a cell-free system. J. Biol. Chem., 272: 2952-2956, 1997.
48. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
49. Pan, H., DeVault, A., Wang-Iverson, D., Ivashkiv, E., Swanson, B., and Sugerman, A. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J. Clin. Pharmacol., 30: 1128-1135, 1990.
50. McDonnel, T. J., Troncoso, P., Brisbay, S. M., Logothesis, C., Chang, L. W. K., Hsieh, J-T., Tu, S-M., and Campbell, M. L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992.
51. Colombel, M., Symmans, F. Gil, S., O'Toole, K., Chopin, D., Benson, M., Olsson, C., Korsmeyer, S., and Buttyan, R. Detection of the apoptosis suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am. J. Pathol., 143: 390-400, 1993.